# CellMist™ Autologous Cells to Treat Deep Second-Degree Burns

> **NCT04890574** · PHASE1 · UNKNOWN · sponsor: **RenovaCare, Inc** · enrollment: 14 (estimated)

## Conditions studied

- Burns
- Burns Second Degree
- Burns Deep Second Degree

## Interventions

- **DEVICE:** CellMist™ System

## Key facts

- **NCT ID:** NCT04890574
- **Lead sponsor:** RenovaCare, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-26
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04890574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04890574, "CellMist™ Autologous Cells to Treat Deep Second-Degree Burns". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04890574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*